These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7945711)

  • 1. Synthesis of substituted [1]benzothieno[2,3-b]pyrazines and their ability to antagonize KCl induced contractions.
    Guerrera F; Salerno L; Sarvà MC; Siracusa MA; Rescifina A; Scalia R; Bianchi A
    Farmaco; 1994; 49(7-8):467-73. PubMed ID: 7945711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 2,3-diarylpyrazines and quinoxalines as selective COX-2 inhibitors.
    Singh SK; Saibaba V; Ravikumar V; Rudrawar SV; Daga P; Rao CS; Akhila V; Hegde P; Rao YK
    Bioorg Med Chem; 2004 Apr; 12(8):1881-93. PubMed ID: 15051057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative inotropic and calcium antagonistic activity of alkyl and arylalkyl phosphonates.
    Bellucci C; Gualtieri F; Scapecchi S; Teodori E; Budriesi R; Chiarini A
    Farmaco; 1989 Dec; 44(12):1167-91. PubMed ID: 2634406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of vasoselective action of mebudipine, a new calcium channel blocker.
    Mirkhani H; Dirin M; Youssef-Zayeh I
    Vascul Pharmacol; 2004 Aug; 42(1):23-9. PubMed ID: 15664884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines.
    Guillon J; Grellier P; Labaied M; Sonnet P; Léger JM; Déprez-Poulain R; Forfar-Bares I; Dallemagne P; Lemaître N; Péhourcq F; Rochette J; Sergheraert C; Jarry C
    J Med Chem; 2004 Apr; 47(8):1997-2009. PubMed ID: 15055999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery.
    Noguera I; Medina P; Segarra G; Martínez MC; Aldasoro M; Vila JM; Lluch S
    Br J Pharmacol; 1997 Oct; 122(3):431-8. PubMed ID: 9351498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasorelaxant effect in rat aortic rings through calcium channel blockage: a preliminary in vitro assessment of a 1,3,4-oxadiazole derivative.
    Bankar GR; Nandakumar K; Nayak PG; Thakur A; Chamallamudi MR; Nampurath GK
    Chem Biol Interact; 2009 Oct; 181(3):377-82. PubMed ID: 19643099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New substituted 1,4-benzoxazine derivatives with potential intracellular calcium activity.
    Bourlot AS; Sánchez I; Dureng G; Guillaumet G; Massingham R; Monteil A; Winslow E; Pujol MD; Mérour JY
    J Med Chem; 1998 Aug; 41(17):3142-58. PubMed ID: 9703461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blocking activity of calycosin, a major active component of Astragali Radix, on rat aorta.
    Wu XL; Wang YY; Cheng J; Zhao YY
    Acta Pharmacol Sin; 2006 Aug; 27(8):1007-12. PubMed ID: 16867251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of endothelium on the aortic contraction induced by norepinephrine and KCl in isolated rat aorta.
    Wong KK
    Artery; 1996; 22(1):55-60. PubMed ID: 8781711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vasodilator mechanism of sulfur dioxide on isolated aortic rings of rats: Involvement of the K+ and Ca2+ channels.
    Zhang Q; Meng Z
    Eur J Pharmacol; 2009 Jan; 602(1):117-23. PubMed ID: 19049805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute and chronic cadmium administration on the vascular reactivity of rat aorta.
    Tzotzes V; Tzilalis V; Giannakakis S; Saranteas T; Papas A; Mourouzis I; Mourouzis C; Zarros A; Pantos C; Cokkinos D; Carageorgiou H
    Biometals; 2007 Feb; 20(1):83-91. PubMed ID: 16802071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contractile effects of angiotensin peptides in rat aorta are differentially dependent on tyrosine kinase activity.
    Petrescu G; Costuleanu M; Slatineanu SM; Costuleanu N; Foia L; Costuleanu A
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):180-7. PubMed ID: 11881120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nicorandil as compared to mixtures of sodium nitroprusside and levcromakalim in isolated rat aorta.
    Cogolludo AL; Pérez-Vizcaíno F; Fajardo S; Ibarra M; Tamargo J
    Br J Pharmacol; 1999 Feb; 126(4):1025-33. PubMed ID: 10193784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological testing of thiosalicylamides as a novel class of calcium channel blockers.
    Mehanna AS; Kim JY
    Bioorg Med Chem; 2005 Jul; 13(13):4323-31. PubMed ID: 15927838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diterpenes isolated from Croton zambesicus inhibit KCl-induced contraction.
    Baccelli C; Block S; Van Holle B; Schanck A; Chapon D; Tinant B; Meervelt LV; Morel N; Quetin-Leclercq J
    Planta Med; 2005 Nov; 71(11):1036-9. PubMed ID: 16320205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological studies on alterations in contractile reactivity in aortas isolated from experimental diabetic rats].
    Kawasaki H
    Hokkaido Igaku Zasshi; 1997 Nov; 72(6):649-65. PubMed ID: 9465317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of calcium channel blockers with different agonists in aorta from normal and diseased rats.
    Bhugra P; Gulati OD
    Indian J Physiol Pharmacol; 1996 Apr; 40(2):109-19. PubMed ID: 9062804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.